The United States Food and Drug Administration (U.S. FDA) Office of International Programs’ (OIP) China Office and the Small Business and Industry Assistance Program (SBIA) in the Center for Drug Evaluation and Research (CDER) are pleased to announce the online availability of additional resources translated in Chinese.
Two webinars recently translated into Chinese have been added to the SBIA Resources Page. These webinars help address common questions impacting a global audience involved in manufacturing and distributing pharmaceuticals.
Two webinars recently translated into Chinese have been added to the SBIA Resources Page. These webinars help address common questions impacting a global audience involved in manufacturing and distributing pharmaceuticals.
- An Overview of FDA’s Guidance – Drug Supply Chain Security Act Implementation---
Identification of Suspect Product and Notification - Establishment Registration and Listing for Human Drugs---Highlighting Recent Amendments.
Further resources may be found at SBIA Resources in Chinese.
We welcome feedback on these resources and suggestions for future translations of resources. Please contact the U.S. FDA China Office at USFDAChinaOffice@fda.hhs.gov with comments or questions. 
.png)
No hay comentarios:
Publicar un comentario